Cargando…
Discovery and Development of Inhibitors of the Plasmodial FNT-Type Lactate Transporter as Novel Antimalarials
Plasmodium spp. malaria parasites in the blood stage draw energy from anaerobic glycolysis when multiplying in erythrocytes. They tap the ample glucose supply of the infected host using the erythrocyte glucose transporter 1, GLUT1, and a hexose transporter, HT, of the parasite’s plasma membrane. Per...
Autores principales: | Nerlich, Cornelius, Epalle, Nathan H., Seick, Philip, Beitz, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624176/ https://www.ncbi.nlm.nih.gov/pubmed/34832972 http://dx.doi.org/10.3390/ph14111191 |
Ejemplares similares
-
The Plasmodium Lactate/H(+) Transporter PfFNT Is Essential and Druggable In Vivo
por: Davies, Heledd, et al.
Publicado: (2023) -
Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale
por: Golldack, André, et al.
Publicado: (2017) -
Cell-Free and Yeast-Based Production of the Malarial Lactate Transporter, PfFNT, Delivers Comparable Yield and Protein Quality
por: Hajek, Philipp, et al.
Publicado: (2019) -
Pentafluoro‐3‐hydroxy‐pent‐2‐en‐1‐ones Potently Inhibit FNT‐Type Lactate Transporters from all Five Human‐Pathogenic Plasmodium Species
por: Walloch, Philipp, et al.
Publicado: (2021) -
Structural characterization of the Plasmodium falciparum lactate transporter PfFNT alone and in complex with antimalarial compound MMV007839 reveals its inhibition mechanism
por: Peng, Xi, et al.
Publicado: (2021)